Ken Griffin Envista Holdings Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$15.3 - $19.76 $683,910 - $883,272	44,700 Added 282.91%	60,500 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$16.0 - $21.1 $6.61 Million - $8.71 Million	-412,900 Reduced 96.31%	15,800 $262,000
Q1 2024 May 15, 2024	BUY	$20.64 - $25.45 $7.63 Million - $9.41 Million	369,600 Added 625.38%	428,700 $9.17 Million
Q4 2023 Feb 14, 2024	BUY	$21.06 - $27.57 $303,264 - $397,008	14,400 Added 32.21%	59,100 $1.42 Million
Q3 2023 Nov 14, 2023	SELL	$27.56 - $35.7 $101,972 - $132,090	-3,700 Reduced 7.64%	44,700 $1.25 Million
Q2 2023 Aug 14, 2023	SELL	$31.53 - $39.74 $10.6 Million - $13.3 Million	-334,800 Reduced 87.37%	48,400 $1.64 Million
Q1 2023 May 15, 2023	BUY	$32.84 - $42.5 $8.14 Million - $10.5 Million	247,800 Added 183.01%	383,200 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$32.54 - $37.99 $2.32 Million - $2.7 Million	71,200 Added 110.9%	135,400 $4.56 Million
Q3 2022 Nov 14, 2022	BUY	$32.81 - $41.51 $1.46 Million - $1.85 Million	44,500 Added 225.89%	64,200 $2.11 Million

319

203M

695K

82.6K

Ticker NVST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 163,391,008
Market Cap $3.51B
Description
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.